Timing clarification: Equifax’s official schedule says results will be released Tuesday, July 21, 2026 at 6:30 a.m. ET, followed by the call at 8:30 a.m. ET. July 22 is when the replay becomes available, not the report date. (investor.equifax.com)
Equifax enters Q2 with expectations centered almost exactly on management’s guidance:
| Metric | Management’s Q2 guidance | Street consensus | Q2 2025 |
|---|---|---|---|
| Revenue | $1.680B–$1.710B | ~$1.70B | $1.537B |
| Adjusted EPS | $2.15–$2.25 | $2.21 | $2.00 |
| Adjusted EBITDA | $537M–$554M | — | $499M |
| Adjusted EBITDA margin | ~32.2% midpoint | — | 32.5% |
| Margin excluding FICO royalties | 34.3%–34.7% | — | ~33.6% comparable basis |
Consensus implies approximately 10% year-over-year growth in both revenue and adjusted EPS. Because the Street is sitting near the midpoint of guidance, a modest headline beat may not be enough. The stock’s response should depend more on:
Management’s existing full-year outlook is revenue of $6.685B–$6.805B, adjusted EPS of $8.34–$8.74, and more than $1B of free cash flow. (sec.gov)
Mortgage remains the biggest near-term swing factor.
In Q1, total U.S. mortgage revenue rose 38%, including 60% growth in USIS mortgage, but part of that reflected higher FICO score royalty revenue that Equifax passes through at essentially no margin. Management guided Q2 U.S. mortgage revenue to rise more than 20%, but only high single digits excluding FICO royalties. (sec.gov)
That distinction matters:
The backdrop was mixed during Q2. The average 30-year mortgage rate fell to roughly 6.2% in late April but returned to about 6.5% by June. Rates remained high enough to restrain refinancing, although purchase and refinance applications showed intermittent improvement. (freddiemac.com)
What would be encouraging
Main risk
Management had already warned that the strong Q1 mortgage environment weakened late in the quarter. If activity remained soft through Q2 and into July, full-year mortgage assumptions could be reduced despite the large Q1 beat.
This is the first earnings report since Fannie Mae and Freddie Mac began limited rollouts of VantageScore 4.0 on April 22.
Approved lenders can now choose VantageScore 4.0 instead of Classic FICO on eligible loans, while lenders outside the limited rollout must continue using Classic FICO. The rollout therefore began during Q2 but was not yet broadly available. (fanniemae.com)
This matters disproportionately to Equifax’s margins:
The Q2 financial contribution may still be modest because the rollout is limited. The more important disclosures will be:
Investors should not interpret lower mortgage revenue caused by conversion as inherently negative. Replacing a roughly $10 zero-margin FICO pass-through with a lower-priced, high-margin VantageScore could reduce revenue while increasing EBITDA.
Workforce Solutions is Equifax’s highest-margin and strategically most important segment. In Q1:
The Q2 comparison is more difficult, particularly in government, because Equifax began benefiting from a large Social Security Administration contract during Q2 2025. Management consequently expected government revenue to be roughly flat sequentially.
Government verification
The long-term pipeline remains attractive due to state and federal efforts to improve income verification, benefit eligibility and improper-payment detection. But deal signings and system activations can be uneven. Investors should look for evidence that the pipeline—described in Q1 as more than twice the prior-year level—is converting into 2026 or 2027 revenue.
Talent Solutions
Equifax has been outperforming a weak white-collar hiring market through pricing, higher Work Number hit rates and additional background-screening products. The broader labor market did not materially improve late in Q2: June payroll growth slowed to 57,000, while May job openings and hiring were broadly unchanged. (bls.gov)
Continued high-single-digit Talent Solutions growth would therefore suggest company-specific share gains rather than help from the macro environment.
Consumer lending
Auto and personal-loan verification had posted seven consecutive quarters of double-digit growth entering Q2. Any meaningful deceleration would raise questions about consumer-credit demand; sustained double-digit growth would support Equifax’s claim that The Work Number is expanding beyond mortgage.
USIS Q1 revenue rose 21%, but only 8% excluding FICO, and diversified-market growth was a more modest 3%. Management expected diversified USIS growth to accelerate to the mid-single digits in Q2.
The key driver should be deployment of The Work Number Indicator across mortgage, auto, card and personal loans. Equifax provides limited income and employment attributes alongside the credit file at no additional charge, seeking to win credit-file share and drive subsequent paid verification activity.
Investors should look for:
A miss here would be more concerning than a mortgage-related revenue miss because diversified USIS is less exposed to interest-rate volatility and should better reflect product execution.
Management guided Q2 adjusted EBITDA to $537M–$554M, or roughly 9% year-over-year growth. Reported margin is expected near 32.2%, slightly below last year because FICO pass-through revenue has increased.
Excluding FICO royalties, however, management expects margin of 34.3%–34.7%, more than 80 basis points higher year over year. Full-year guidance calls for approximately 75 basis points of ex-FICO expansion, ahead of Equifax’s 50-basis-point long-term framework. (marketscreener.com)
Investors should focus on whether Equifax is delivering:
A headline revenue beat driven mainly by FICO royalties, without corresponding ex-FICO margin expansion, would be low quality.
On July 7, Equifax agreed to acquire Mexican credit bureau Círculo de Crédito for a $750 million enterprise value. The target is expected to generate approximately:
The price equates to roughly 12 times trailing adjusted EBITDA. The deal is expected to close in Q4 and be adjusted-EPS accretive in the first full year. (investor.equifax.com)
The acquisition should have little or no effect on Q2 and limited effect on 2026 revenue. Its immediate relevance is capital allocation:
The strategic logic is credible—Mexico offers faster credit-market growth and substantial alternative-data opportunities—but investors may demand clear returns given the stock’s weakness and the alternative of repurchasing shares.
EFX closed July 20 at $180.11, down approximately 16% from the beginning of 2026 and about 9% since the day before Q1 earnings, despite the strong Q1 beat. It has recovered roughly 14% from its May low.
At the current price, the shares trade around:
That is not a distressed valuation, but expectations appear meaningfully lower than they were earlier in the year. The stock may therefore respond well to stable guidance and credible VantageScore upside even without a large Q2 beat.
This is primarily a guidance and VantageScore report, not an EPS-surprise event. Consensus is already near the midpoint of Equifax’s Q2 range, so a routine beat may carry limited weight.
The most important question is whether Equifax can demonstrate that its earnings growth is becoming less dependent on mortgage volumes and more driven by:
If those elements are intact and full-year guidance is maintained or raised, the stock’s year-to-date underperformance creates a favorable setup. If management instead reduces mortgage expectations without quantifying VantageScore or diversified-market offsets, the report could reinforce concerns that the Q1 strength was temporary.